Phase 2 study of oral panobinostat (LBH589) with or without...

Leukemia 2014 / 3 Vol. 28; Iss. 3

Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients

Platzbecker, U, Al-Ali, H K, Gattermann, N, Haase, D, Janzen, V, Krauter, J, Götze, K, Schlenk, R, Nolte, F, Letsch, A, Ottmann, O G, Kündgen, A, Lübbert, M, Germing, U, Wermke, M, Reinhard, H, Weiss,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Leukemia
DOI:
10.1038/leu.2013.325
Date:
March, 2014
File:
PDF, 467 KB
english, 2014
Conversion to is in progress
Conversion to is failed